Mumbai: Ajanta Pharmaceuticals has signed an licensing contract with Canada-based Prollenium Medical Technologies to exclusively market the latter’s dermal filler ‘Revanesse’ in the Indian market.
A message from Ajanta Pharmaceuticals said that the Prollenium Technologies has its proficiency in “medical aesthetics.”
The note added that revanesse adds volume and polishes out deficiencies in the skin and also helps protect delicate skin areas from maturating.